It is the highest number of cases recorded since the virus became notifiable. A free RSV vaccine will be made available to pregnant people to protect them and their unborn babies from February 3.

Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...

Novavax (NVAX) closed at $9.34 in the latest trading session, marking a +1.3% move from the prior day. The average of price targets set by Wall Street analysts indicates a potential upside of 81.6 ...

It looks like this virus, which leads to symptoms resembling the common cold, has a close connection to respiratory syncytial virus (RSV). After all, both viruses cause respiratory illnesses and have ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced progress in Q4 2024 advancing its corporate growth strategy through ...

Novavax (NVAX) closed at $9.34 in the latest trading session, marking a +1.3% move from the prior day. The average of price targets set by Wall Street analysts indicates a potential upside of 81.6% in ...

The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...

Novavax’s COVID-19 vaccine produced higher levels of neutralising antibodies than produced by recovered patients in an early trial, paving the way for a phase 3 trial by next month and potential ...

A clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2, only slightly lower than the 96% efficacy seen with the original strain of the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The intended audience for the activity is ...